Gut microbiota transmission induces cognitive impairment through amyloid pathology in wild-type mice

Chenyi Yang1, Wei Qi1, Wei Li1

  • 1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.

Neuroscience
|February 27, 2026
PubMed

Insights

Early-life exposure to Alzheimer's disease (AD) mouse microbiota via co-housing induced gut dysbiosis, amyloid pathology, and cognitive deficits in wild-type mice. Probiotic treatment mitigated these AD-like effects.

Area of Science:

  • Neuroscience
  • Microbiology
  • Genetics

Background:

  • Alzheimer's disease (AD) is the primary cause of dementia, often sporadic and influenced by non-genetic factors like gut microbiota.
  • Early-life microbial transmission between AD transgenic (Tg) and wild-type (WT) mice can cause cognitive issues, but mechanisms are unclear.

Purpose of the Study:

  • To investigate the mechanisms of gut microbiota transfer and its impact on cognitive function and amyloid pathology in WT mice exposed to AD Tg mice during early life.
  • To evaluate the therapeutic efficacy of a specific probiotic intervention.

Main Methods:

  • One-month-old WT mice were co-housed with 5XFAD (AD Tg) mice for three months.
  • Gut microbiota composition was analyzed using 16S rRNA sequencing.
  • Brain amyloid-β 42 (Aβ42) levels were measured using ELISA and a nanoplasmonic sensor.
  • Cognitive function was assessed via Morris water maze and Barnes maze.
  • Probiotic treatment (Lactobacillus reuteri and Bifidobacterium pseudolongum) was administered.

Main Results:

  • WT mice co-housed with AD Tg mice (ADWT) exhibited gut dysbiosis with microbial profiles similar to AD Tg mice.
  • ADWT mice showed elevated brain Aβ42 levels and developed cognitive impairments.
  • Probiotic intervention successfully altered gut microbial composition and reduced Aβ42 levels in the cortex and hippocampus of ADWT mice.

Conclusions:

  • Microbiota transfer via early-life co-housing induces gut dysbiosis, amyloid pathology, and cognitive deficits in WT mice.
  • Targeted probiotic intervention can effectively mitigate these microbiota-driven Alzheimer's disease-like effects.
  • These findings support a non-genetic, microbiota-driven pathway in AD pathogenesis.

Related Concept Videos

Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...